DEC 19, 2018 6:51 PM PST

UTI Infection Becoming a Common Reoccurrence?

WRITTEN BY: Nicholas Breehl

A Urinary tract infection (UTI) is one reason many patients take a trip to visit their physician. Upon clearing of the infection, some individuals find that the annoyance has returned and rather quickly, leaving them questioning the effectiveness of the treatment. In a recent study published in the scientific journal known as PLOS Pathogens, a team of researchers sheds light on what could be going on.

A urinary tract infection is an infection in any part of your urinary system —  kidneys, ureters, bladder, and urethra. Most infections involve the lower urinary tract — the bladder and the urethra.

Women are at higher risk of developing a UTI than are men. Infection limited to your bladder can be painful and annoying. However, serious consequences can occur if a UTI spreads to your kidneys.

Urinary tract infections are widespread and can be highly recurrent, with 1–2% of women suffering from six or more frequent episodes per year. The high incidence of recurrent UTI, including recurrent infections caused by the same bacterial strain that produced the first infection, suggests that at least some women do not mount a protective adaptive immune response to UTI.

Many patients suffer from highly recurrent urinary tract infections caused by Escherichia coli, which are genetically diverse bacteria. Recurrent episodes are often caused by the same E. coli strain that created the first infection, suggesting that some patients may not develop a protective immune response.

The researchers, making use of bladder infected mouse models, discover that two E. coli strains behave differently. One strain, known as UTI89, infects the bladder indefinitely, whereas another strain called CFT073 is cleared within eight weeks.

Interestingly, mice which had already been exposed to CFT073 and treated with antibiotics were henceforth protected from reinfection, however, remained susceptible to UTI89 infection. In contrast to this finding, mice with a UTI89 infection and antibiotics were susceptible to recurrent UTI when challenged with either strain.

“We found that depleting T cells, immune cells important for developing protection against infection prevented mice from clearing their CFT073 infections and made them susceptible to recurrent CFT073 UTI. Thus, while infection with one E. coli strain could trigger a protective immune response, another strain sidestepped this response” shares authors of the publication.

“Our findings demonstrate the complex interplay between the broad genetic diversity of UPEC and the host innate and adaptive immune responses during UTI. A better understanding of these host-pathogen interactions is urgently needed for effective drug and vaccine development in the era of increasing antibiotic resistance,” shares the authors of the study.

The findings to this study shed new light on immune responses to UTI and may be essential for drug and vaccine development.

Sources: PLOS Pathogen, Mayo Clinic, YouTube

About the Author
You May Also Like
NOV 04, 2021
Cancer
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
NOV 04, 2021
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
Despite the incremental success immune checkpoint inhibitors (ICI) have attributed to the cancer treatment landscape rec ...
NOV 03, 2021
Plants & Animals
A Samoan Plant May Reduce Inflammation as Well as Ibuprofen
NOV 03, 2021
A Samoan Plant May Reduce Inflammation as Well as Ibuprofen
To the people of Samoa, the medicinal qualities of a tree known as matalafi are well known. Now scientists are bringing ...
NOV 16, 2021
Immunology
How a BBQ Lighter Inspired a New Vaccine Technology
NOV 16, 2021
How a BBQ Lighter Inspired a New Vaccine Technology
It’s the size of a pen, weighs as much as two AA batteries, and works without a power source. A new microneedle de ...
NOV 18, 2021
Immunology
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
NOV 18, 2021
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
Antibody therapies harness the immune system's power to fight a broad spectrum of diseases, from cancer to infectiou ...
DEC 16, 2021
Immunology
Just Add Water: Super Stable Freeze-Dried COVID Vaccines
DEC 16, 2021
Just Add Water: Super Stable Freeze-Dried COVID Vaccines
  In the face of a viral threat with pandemic potential, developing a potent vaccine is just one half of the battle ...
JAN 01, 2022
Health & Medicine
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
JAN 01, 2022
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
Novavax, a Maryland-based biotechnology company, gets approval for its more traditional protein-subunit COVID-19 vaccine ...
Loading Comments...